Table 3.
Antibiotic susceptibilities of Staphylococcus aureus, Enterobacteriaceae and nonfermenting isolates from nasal swabs
| Species | n | Susceptibility (%)a to: |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN | AMP | OXA | CXM | CTX | MER | LEV | CIP | RIF | CLI | SXT | GEN | ||
| Staphylococcus aureus | 768 | 35.7 | — | 98.0 | — | — | — | 98.4 | — | 100 | 90.0 | 99.6 | 98.8 |
| Enterobacteriaceae | |||||||||||||
| Klebsiella oxytoca | 121 | — | — | — | 98.4 | 99.2 | 100 | — | 100 | — | — | 100 | 100 |
| Escherichia coli | 115 | — | 80.0 | — | 98.3 | 100 | 100 | — | 99.1 | — | — | 95.7 | 98.3 |
| Proteus mirabilis | 113 | — | 85.8 | — | 99.1 | 100 | 100 | — | 99.1 | — | — | 92.0 | 98.2 |
| Citrobacter koseri | 68 | — | — | 73.5 | 89.7 | 100 | — | 100 | — | — | 100 | 98.5 | |
| Pantoea agglomerans | 58 | — | 69.0 | — | 91.4 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Enterobacter aerogenes | 48 | — | — | — | 100 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Klebsiella pneumoniae | 45 | — | — | — | 93.3 | 100 | 100 | — | 100 | — | — | 97.8 | 97.8 |
| Citrobacter freundii | 42 | — | — | — | 100 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Enterobacter cloacae | 26 | — | — | — | 65.4 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Raoultella ornithinolytica | 20 | — | — | — | 95.0 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Serratia marcescens | 18 | — | — | — | 11.1 | 100 | 100 | — | 100 | — | — | 100 | 88.9 |
| Hafnia alvei | 14 | — | — | — | 92.9 | 100 | 100 | — | 100 | — | — | 100 | 100 |
| Morganella morganii | 14 | — | — | — | — | 71.4 | 100 | — | 92.9 | — | — | 92.9 | 92.9 |
| Serratia liquefaciens | 10 | — | — | — | — | 100 | 100 | — | 100 | — | — | 100 | 10.0 |
| Nonfermenting pathogens | |||||||||||||
| Acinetobacter baumannii | 21 | — | — | — | — | — | 100 | — | 100 | — | — | — | 100 |
| Stenotrophomonas maltophilia | 14 | — | — | — | — | — | — | — | 100 | — | — | 100 | — |
| Pseudomonas putida | 12 | — | — | — | — | — | 50.0 | — | 100 | — | — | — | 91.7 |
AMP, ampicillin; CIP, ciprofloxacin; CLI, clindamycin; CTX, cefotaxime; CXM, cefuroxime; GEN, gentamicin; LEV, levofloxacin; MER, meropenem; OXA, oxacillin/cefoxitin; PEN, benzylpenicillin; RIF, rifampicin; SXT, trimethoprim–sulfamethoxazole.
Percentage of susceptible isolates for the respective antibiotic. On species level, data are shown for those species for which the number of isolates tested was at least ten. Data are sorted in order of isolates tested for different groups of bacteria. If the same microorganism was isolated more than once from the same participant (at different study time points), only the first isolate was included in the calculation. Intermediate test results are counted as nonsusceptible. A dash indicates that antibiotic was not tested.